WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/159903    International Application No.:    PCT/US2011/040710
Publication Date: 22.12.2011 International Filing Date: 16.06.2011
C07D 491/044 (2006.01), A61K 31/407 (2006.01), A61P 25/18 (2006.01)
Applicants: DR. REDDY'S LABORATORIES LTD. [IN/IN]; 8-2-337, Road No. 3, Banjara Hills, Hyderabad, 500 034, Andhra Pradesh (IN) (For All Designated States Except US).
DR. REDDY'S LABORATORIES, INC. [US/US]; 200 Somerset Corporate Boulevard 7th Floor Bridgewater, New Jersey 08807 (US) (For All Designated States Except US).
KATKAM, Srinivas [IN/IN]; (IN) (For US Only).
POLAVARAPU, Srinivas [IN/IN]; (IN) (For US Only).
YADDANAPUDI, Venkata Madhavi [IN/IN]; (IN) (For US Only).
VINIGARI, Krishna [IN/IN]; (IN) (For US Only).
PAGADALA, Narasimha Rao [IN/IN]; (IN) (For US Only).
SAGYAM, Rajeshwar Reddy [IN/IN]; (IN) (For US Only)
Inventors: KATKAM, Srinivas; (IN).
POLAVARAPU, Srinivas; (IN).
YADDANAPUDI, Venkata Madhavi; (IN).
VINIGARI, Krishna; (IN).
PAGADALA, Narasimha Rao; (IN).
SAGYAM, Rajeshwar Reddy; (IN)
Agent: McKENZIE, Thomas Charles; Dr. Reddy's Laboratories, Inc. 200 Somerset Corporate Boulevard - 7th floor Bridgewater, New Jersey 08807 (US)
Priority Data:
1695/CHE/2010 18.06.2010 IN
61/372,566 11.08.2010 US
3386/CHE/2010 11.11.2010 IN
61/427,933 29.12.2010 US
Abstract: front page image
(EN)Aspects of the present application relate to a microcrystalline monoclinic form of asenapine maleate represented by structural Formula (I); processes for its preparation; and pharmaceutically acceptable dosage forms thereof.
(FR)Des aspects de la présente invention concernent une forme monoclinique microcristalline de maléate d'asénapine représentée par la formule structurale I ; des procédés pour sa préparation ; et des formes pharmaceutiques pharmaceutiquement acceptables de celle-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)